Abstract
Purpose
To determine the underlying reasons for the non-visualization of polyps on en face optical coherence tomography angiography (OCTA) in patients with polypoidal choroidal vasculopathy (PCV).
Methods
A cross-sectional study of consecutive treatment-naïve 30 eyes with active PCV was included. Results of fundus photography, fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), spectral domain optical coherence tomography (SD-OCT), and en face OCTA were analyzed.
Results
A total of 64 active polyps were found on FFA and ICGA in 30 eyes. On OCTA, 42/64 (65.6%) polyps were visualized, while 22/64 (34.4%) polyps were non-visualized. There were no significant differences in the size (P = 0.723) and filling time of polyps (P = 0.558) between the two groups. However, polypoidal lesions were less common in the non-visualized group (P < 0.001). The height of the polyps on SD-OCT was 243.95 ± 114.24 μm in the non-visualized group, which was higher than those (188.00 ± 87.93 μm) in the visualized group (P = 0.048). Moreover, more pulsatile polyps (72.7%) were found in the non-visualized group than those (2.4%) in the visualized group (P < 0.001). Four of the 22 polyps in the non-visualized group (18.2%) were located under a thick subretinal hemorrhage, and two of 22 invisible polyps (9.6%) located under and parallel to the retinal vessel in the inner layer of retina.
Conclusions
Our results revealed that the height of the polyps, and not the size and pulsation of the polyps, correlated with the visualization of the polyps on OCTA. Polyps that were pulsating in early ICGA were difficult to be visualized on OCTA, which is the most possible reason for the non-visualization. Coverage with thick subretinal hemorrhage or retina vessels was another reason for the non-visualization of the polyps in active PCV on OCTA.
Similar content being viewed by others
References
Yannuzzi LA, Sorenson J, Spaide RF, Lipson B (1990) Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina (Philadelphia, Pa) 10:1–8
Laude A, Cackett PD, Vithana EN, Yeo IY, Wong D, Koh AH, Wong TY, Aung T (2010) Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease? Prog Retin Eye Res 29:19–29. https://doi.org/10.1016/j.preteyeres.2009.10.001
Coscas F, Coscas G, Querques G, Massamba N, Querques L, Bandello F, Souied EH (2012) En face enhanced depth imaging optical coherence tomography of fibrovascular pigment epithelium detachment. Invest Ophthalmol Vis Sci 53:4147–4151. https://doi.org/10.1167/iovs.12-9878
Cheung CM, Laude A, Wong W, Mathur R, Chan CM, Wong E, Wong D, Wong TY, Lim TH (2015) Improved specificity of polypoidal choroidal vasculopathy diagnosis using a modified EVEREST criteria. Retina (Philadelphia, Pa) 35:1375–1380. https://doi.org/10.1097/iae.0000000000000482
Liu R, Li J, Li Z, Yu S, Yang Y, Yan H, Zeng J, Tang S, Ding X (2016) Distinguishing polypoidal choroidal vasculopathy from typical neovascular age-related macular degeneration based on spectral domain optical coherence tomography. Retina (Philadelphia, Pa) 36:778–786. https://doi.org/10.1097/iae.0000000000000794
Chaikitmongkol V, Khunsongkiet P, Patikulsila D, Ratanasukon M, Watanachai N, Jumroendararasame C, Mayerle CB, Han IC, Chen CJ, Winaikosol P, Dejkriengkraikul C, Choovuthayakorn J, Kunavisarut P, Bressler NM (2018) Color fundus photography, optical coherence tomography, and fluorescein angiography in diagnosing polypoidal choroidal vasculopathy. Am J Ophthalmol 192:77–83. https://doi.org/10.1016/j.ajo.2018.05.005
Koh A, Lee WK, Chen LJ, Chen SJ, Hashad Y, Kim H, Lai TY, Pilz S, Ruamviboonsuk P, Tokaji E, Weisberger A, Lim TH (2012) EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina (Philadelphia, Pa) 32:1453–1464. https://doi.org/10.1097/IAE.0b013e31824f91e8
Jia Y, Tan O, Tokayer J, Potsaid B, Wang Y, Liu JJ, Kraus MF, Subhash H, Fujimoto JG, Hornegger J, Huang D (2012) Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express 20:4710–4725. https://doi.org/10.1364/oe.20.004710
Bradley PD, Sim DA, Keane PA, Cardoso J, Agrawal R, Tufail A, Egan CA (2016) The evaluation of diabetic macular ischemia using optical coherence tomography angiography. Invest Ophthalmol Vis Sci 57:626–631. https://doi.org/10.1167/iovs.15-18034
Srour M, Querques G, Semoun O, El Ameen A, Miere A, Sikorav A, Zambrowski O, Souied EH (2016) Optical coherence tomography angiography characteristics of polypoidal choroidal vasculopathy. Br J Ophthalmol. https://doi.org/10.1136/bjophthalmol-2015-307892
Srour M, Querques G, Souied EH (2016) Optical coherence tomography angiography of idiopathic polypoidal choroidal vasculopathy. Dev Ophthalmol 56:71–76. https://doi.org/10.1159/000442781
Cheung CM, Yanagi Y, Mohla A, Lee SY, Mathur R, Chan CM, Yeo I, Wong TY (2016) Characterization and differentiation of polypoidal choroidal vasculopathy using swept source optical coherence tomography angiography. Retina (Philadelphia, Pa). https://doi.org/10.1097/iae.0000000000001391
Tanaka K, Mori R, Kawamura A, Nakashizuka H, Wakatsuki Y, Yuzawa M (2017) Comparison of OCT angiography and indocyanine green angiographic findings with subtypes of polypoidal choroidal vasculopathy. Br J Ophthalmol 101:51–55. https://doi.org/10.1136/bjophthalmol-2016-309264
Takayama K, Ito Y, Kaneko H, Kataoka K, Sugita T, Maruko R, Hattori K, Ra E, Haga F, Terasaki H (2017) Comparison of indocyanine green angiography and optical coherence tomographic angiography in polypoidal choroidal vasculopathy. Eye (London, England) 31:45–52. https://doi.org/10.1038/eye.2016.232
Inoue M, Balaratnasingam C, Freund KB (2015) Optical coherence tomography angiography of polypoidal choroidal vasculopathy and polypoidal choroidal neovascularization. Retina (Philadelphia, Pa) 35:2265–2274. https://doi.org/10.1097/iae.0000000000000777
Wang M, Zhou Y, Gao SS, Liu W, Huang Y, Huang D, Jia Y (2016) Evaluating polypoidal choroidal vasculopathy with optical coherence tomography angiography. Invest Ophthalmol Vis Sci 57:OCT526–OCT532. https://doi.org/10.1167/iovs.15-18955
Fukuyama H, Iwami H, Araki T, Ishikawa H, Ikeda N, Gomi F (2018) Indocyanine green dye filling time for Polypoidal lesions in polypoidal choroidal vasculopathy affects the visibility of the lesions on OCT angiography. Ophthalmol Retina 2:803–807. https://doi.org/10.1016/j.oret.2017.11.016
Seong S, Choo HG, Kim YJ, Kim JY, Lee JH, Oh HS, You YS, Kim SH, Kwon OW (2019) Novel findings of polypoidal choroidal vasculopathy via optical coherence tomography angiography. Korean J Ophthalmol 33:54–62. https://doi.org/10.3341/kjo.2018.0048
Cheung CMG, Lai TYY, Ruamviboonsuk P, Chen SJ, Chen Y, Freund KB, Gomi F, Koh AH, Lee WK, Wong TY (2018) Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management. Ophthalmology 125:708–724. https://doi.org/10.1016/j.ophtha.2017.11.019
Shin JY, Lee JM, Byeon SH (2015) Anti-vascular endothelial growth factor with or without pneumatic displacement for submacular hemorrhage. Am J Ophthalmol 159:904–914 e901. https://doi.org/10.1016/j.ajo.2015.01.024
de Carlo TE, Bonini Filho MA, Chin AT, Adhi M, Ferrara D, Baumal CR, Witkin AJ, Reichel E, Duker JS, Waheed NK (2015) Spectral-domain optical coherence tomography angiography of choroidal neovascularization. Ophthalmology 122(6):1228–1238
Jia Y, Bailey ST, Wilson DJ, Tan O, Klein ML, Flaxel CJ, Potsaid B, Liu JJ, Lu CD, Kraus MF, Fujimoto JG, Huang D (2014) Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. Ophthalmology 121(7):1435–1444
Huang Y-M, Hsieh M-H, Li A-F, Chen S-J (2017) Sensitivity, specificity, and limitations of optical coherence tomography angiography in diagnosis of polypoidal choroidal vasculopathy. J Ophthalmol 2017:1–7
Cheung CMG, Yanagi Y, Akiba M, Tan A, Mathur R, Chan CM, Yeo I, Wong TY (2018) Improved detection and diagnosis of polypoidal choroidal vasculopathy using a combination of optical coherence tomography and optical coherence tomography angiography. Retina (Philadelphia, Pa). https://doi.org/10.1097/iae.0000000000002228
Kuroiwa S, Tateiwa H, Hisatomi T, Ishibashi T, Yoshimura N (2004) Pathological features of surgically excised polypoidal choroidal vasculopathy membranes. Clin Exp Ophthalmol 32(3):297–302
Puliafito CA (2014) OCT angiography: the next era of OCT technology emerges. Ophthalmic Surgery, Lasers and Imaging Retina 45(5):360–360
Acknowledgments
The authors thank all patients who participated in this study. The authors have full control of all primary data, and they agree to allow Graefe’s Archive for Clinical and Experimental Ophthalmology to review their data upon request.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This study was approved by the Institutional Review Board of the Zhongshan Ophthalmic Center, Sun Yat-sen University. All investigations followed the tenets of the Declaration of Helsinki.
Informed consent
Informed consent was obtained from all individual participants included in the prospective study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhan, Z., Sun, L., Jin, C. et al. Comparison between non-visualized polyps and visualized polyps on optical coherence tomography angiography in polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 257, 2349–2356 (2019). https://doi.org/10.1007/s00417-019-04445-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-019-04445-5